IDEXX Laboratories Inc. 8-K Filing: Key Updates for Investors (Feb 2025)

Based on the provided section of the financial report, here are the key pieces of information and insights extracted:

1. Entity Information:

• Company Name: IDEXX Laboratories Inc.
• CIK Number: 0000874716
• SEC Central Index Key: 000-19271
• EIN: 01-0393723
• Address: One IDEXX Drive, Westbrook, ME 04092
• Contact Number: 207-556-0300

2. Filing Information:

• Filing Type: 8-K (a report used to notify investors of major events that are important to shareholders)
• Filing Date: February 13, 2025

3. Stock Information:

• Stock Type: Common Stock
• Par Value: $0.10 per share
• Stock Symbol: IDXX
• Exchange: NASDAQ

4. Filing Context:

• The report relates to a specific event or disclosure that occurred on the same day as the filing, February 13, 2025.

5. General Observations:

• The filing is categorized under "DE" which indicates that it is a definitive agreement or related to certain transactions.
• The document indicates that it is not applicable for certain sections, possibly relating to financials or specific disclosures that do not apply to this 8-K.

Overall, this 8-K filing provides essential updates regarding IDEXX Laboratories Inc., particularly for investors and analysts looking for timely information on company developments or events that could affect stock performance.